FSHR rs6167: Understanding Ovarian Response Genetics

What each genotype means

What is the rs6167 Variant?

The rs6167 variant is a single nucleotide polymorphism (SNP) located within the FSHR gene on chromosome 2. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. The FSHR gene provides instructions for making the follicle-stimulating hormone receptor, a protein that sits on the surface of specific cells in the ovaries and testes. By acting as a docking station for follicle-stimulating hormone (FSH), this receptor plays a critical role in reproductive health, including the development of ovarian follicles and the regulation of the menstrual cycle. Because rs6167 is situated within this gene, researchers have long hypothesized that variations at this site might influence the structure or function of the receptor, potentially altering how the body responds to both natural and exogenous (medically administered) FSH.

The Role of the FSHR Gene

The FSHR gene is essential for normal reproductive function. The receptor it encodes is a G protein-coupled receptor that transmits signals into the cell when FSH binds to it. This signaling pathway is vital for the maturation of ovarian follicles in women and the production of sperm in men. Mutations in the FSHR gene can lead to significant clinical conditions, such as ovarian dysgenesis or ovarian hyperstimulation syndrome, where the receptor's function is either severely impaired or abnormally heightened. While rare, severe mutations can cause primary ovarian insufficiency. In the context of common variants like rs6167, the focus is not on disease-causing mutations but on subtle differences that may contribute to the natural variation in how individuals respond to hormonal signals. Understanding these pathways is a major area of study in reproductive endocrinology, particularly for optimizing fertility treatments.

Research and Evidence Strength

The evidence linking rs6167 to specific clinical outcomes is currently considered limited. While many studies have explored the impact of various FSHR polymorphisms on ovarian response during controlled ovarian stimulation—a process used in in vitro fertilization (IVF)—the results have been mixed. Some research suggests that certain genotypes may correlate with the amount of medication required to stimulate the ovaries or the number of oocytes retrieved, but these findings are not always consistent across different study populations. The GWAS Catalog and other databases track these associations, but it is important to note that reproductive traits are complex and influenced by many genes, environmental factors, and age. Because the evidence is not definitive, rs6167 is not currently used as a standard clinical diagnostic tool to predict fertility outcomes or to dictate specific medical treatment plans.

Population Frequency

The rs6167 variant is common across global populations, meaning that the different versions of this SNP are widely distributed among diverse ancestral groups. While specific minor allele frequencies can vary depending on the population studied, it is generally observed at a frequency that makes it a standard part of human genetic diversity. This high prevalence is typical for many common variants that do not cause severe disease but may contribute to subtle physiological differences. Because it is common, researchers have been able to study it in large cohorts, though the variability in study results highlights the complexity of linking common genetic variants to specific clinical traits. As with many common SNPs, the frequency data is continuously updated in large-scale genomic databases like gnomAD, which provide a clearer picture of how this variant is distributed across different world populations.

What This Information Means for You

If you have information about your rs6167 genotype, it is important to view it as a piece of data within a much larger, complex biological puzzle. This variant is not a diagnostic test for fertility, nor can it predict your personal response to medical treatments with certainty. Genetic associations observed in research studies are statistical trends across large groups of people and do not necessarily apply to any single individual. If you are undergoing fertility treatments or have concerns about your reproductive health, you should always discuss your specific situation, including any genetic information you may have, with a qualified reproductive endocrinologist or a fertility specialist. They can provide context based on your clinical history, hormone levels, and other diagnostic tests. Never use genetic information to make decisions about medication dosing or to alter your treatment plan without direct guidance from your healthcare provider.

Frequently asked questions

Sources & further reading

Related variants in FSHR